About This Treatment Guide


About This Treatment Guide

The Oncology Group of CMPMedica, publisher of ONCOLOGY and Oncology NEWS International, and the website, cancernetwork.com, is pleased to present Cancer Management: A Multidisciplinary Approach, 11th edition. Cancer Management: A Multidisciplinary Approach is designed to present important clinical information concisely, uniformly, and logically, emphasizing the natural history of the malignancy, screening and diagnosis, staging and prognosis, and treatment.

The fundamental principle behind this comprehensive treatment guide is the importance of a truly integrated, multidisciplinary approach to the management of the patient with cancer. Accordingly, the discussion of each disease site combines the perspectives of medical oncology, surgical oncology, and radiation oncology, as appropriate. Further, each of the book’s medical editors represent a particular discipline.

The Oncology Group would like to thank the contributors and all involved in the development and production of this important handbook. In particular, we thank the book’s principal editors:


Richard Pazdur, MD

(Medical Oncology)
US Food and Drug Administration

Lawrence D. Wagman, MD

(Surgical Oncology)
Center for Cancer Prevention and Treatment, St. Joseph Hospital

Kevin A. Camphausen, MD

(Radiation Oncology)
National Cancer Institute

William J. Hoskins, MD

(Gynecologic Oncology)
Memorial Sloan-Kettering Cancer Center

We also thank the staff of The Oncology Group and in particular wish to recognize the efforts of Angela Cibuls and Susan Reckling.

This 11th edition has been produced in an effort to keep pace with the rapidly changing field of oncology. Be sure to visit www.cancernetwork.com, where the full text of this edition will be made available online, with important updates as appropriate.

Please let us know how you use this book, and how we can make it even more valuable. We look forward to hearing from you.


Cara H. Glynn
Beth Scholz



Related Videos
Findings show no difference in overall survival between various treatments for metastatic RCC previously managed with immunotherapy and TKIs.
An epigenomic profiling approach may help pick up the entire tumor burden, thereby assisting with detecting sarcomatoid features in those with RCC.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Cesar Rodriguez, MD, and Frits van Rhee, MD, PhD
Investigators are assessing the use of IORT in patients with borderline resectable or unresectable pancreatic cancer as part of the phase 2 PACER trial.
2 KOLs are featured in this series
2 KOLs are featured in this series
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Related Content